Helvet Health awarded Incyte rare blood cancer brand across Europe

Incyte, an innovative and patient-focused biotech company, selected Helvet Health earlier this year to support the re-branding efforts of a leading treatment in rare blood cancers.

Helvet Health worked to redefine the brand positioning, messaging and entire creative universe, to create more impactful and consistent brand communications across Europe.